Chemung Financial (CMHG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Net income for Q1 2026 was $9.2 million ($1.91 per share), up 52.7% year-over-year, with EPS rising from $1.26 in Q1 2025.
Return on average equity rose to 14.25% from 10.96% year-over-year, and return on average assets increased to 1.36% from 0.88%.
Growth was driven by higher net interest income, increased non-interest income, lower provision for credit losses, and strategic initiatives including Western NY expansion and 2025 balance sheet repositioning.
Opened a new representative office in Buffalo to support Canal Bank division growth.
Financial highlights
Net interest income increased 19.0% year-over-year to $23.6 million, driven by higher loan balances and improved yields.
Non-interest income rose 7.3% to $6.3 million, led by wealth management and brokerage fee growth.
Non-interest expense increased 3.2% to $17.5 million, mainly due to higher compensation costs.
Provision for credit losses decreased to $0.6 million from $1.1 million, reflecting net recoveries and model recalibration.
Book value per share rose to $54.36, and tangible book value per share to $49.85.
Outlook and guidance
Management expects continued loan growth, especially in commercial real estate, and stable asset quality.
The Bank filed to convert from a New York trust company to a national bank, pending regulatory approval.
Capital ratios remain well above regulatory minimums, supporting future growth and dividend capacity.
Management remains focused on consistent, durable performance and community support.
Forward-looking statements highlight risks from economic, regulatory, and geopolitical factors.
Latest events from Chemung Financial
- Votes on directors, executive pay, and auditor ratification set for June 2026 meeting.CMHG
Proxy filing23 Apr 2026 - Annual meeting to elect directors, approve executive pay, and ratify auditor, with focus on governance.CMHG
Proxy filing23 Apr 2026 - Robust loan growth, margin expansion, and capital strength drive continued strategic momentum.CMHG
Investor presentation10 Apr 2026 - All proposals passed; strong 2023 results, expansion, and dividends highlighted.CMHG
AGM 202431 Jan 2026 - Annual non-GAAP net income rose 17.8% to $27.9M, driven by strong loan growth and margin gains.CMHG
Q4 202526 Jan 2026 - Board recommends FOR all proposals, including director elections and new equity plan.CMHG
Proxy Filing2 Dec 2025 - Virtual meeting to elect directors, approve pay, equity plan, and auditor ratification.CMHG
Proxy Filing2 Dec 2025 - All proposals, including director elections and compensation, were approved by majority vote.CMHG
AGM 202526 Nov 2025 - Q3 net income up 36% year-over-year, with strong loan growth and improved margins.CMHG
Q3 20256 Nov 2025